πŸ‡ΊπŸ‡Έ FDA
Patent

US 6835744

3,3-substituted indoline derivatives

expired A61PA61P1/00A61P13/08

Quick answer

US patent 6835744 (3,3-substituted indoline derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Dec 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/00, A61P13/08, A61P15/00, A61P35/00